Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inosine with Chemotherapy in Metastatic TNBC
NCT06355024Phase 2Completed
- Sponsor
- Fudan University
- Start
- May 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of inosine in triple-negative breast cancer (TNBC), sponsored by Fudan University. Started May 2024; status: completed.
02
Drugs
inosine
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT06355024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355024.